Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,007 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Active, Not Recruiting

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

NCT06551519

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Novartis Investigative Site Albstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Hettingen, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Schwetzingen, Baden-Wurttemberg, Germany
View all 89 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

NCT01892722

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Body Weight, +8 more
Locations
  • UAB Childrens Hospital Harbor Center Neurology Dept Birmingham, Alabama, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • University of Miami Miami, Florida, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Alabama Neurology Associates- Site Number : 8400115 Homewood, Alabama, United States
  • Perseverance Research Center- Site Number : 8400138 Scottsdale, Arizona, United States
  • Imaging Endpoints- Site Number : 8400050 Scottsdale, Arizona, United States
  • Sutter East Bay Medical Foundation - Berkeley- Site Number : 8400134 Berkeley, California, United States
View all 311 locations
View Trial Details
Active, Not Recruiting

A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)

NCT05925049

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Research Site Cambridge, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

NCT05269004

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arizona Neuroscience Research LLC Phoenix, Arizona, United States
  • MS Center of California Laguna Hills, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
View all 235 locations
View Trial Details

Related conditions